Skip to main content

Table 1 Patient demographic and clinical characteristics (n = 17)

From: Pain in castration-resistant prostate cancer with bone metastases: a qualitative study

Characteristic  
Age in years, mean [range] 71.1 [53 - 86]
Mean years since prostate cancer diagnosis 7.0
Mean years since onset of bone metastases 1.7
Cancer stage*  
   Well differentiated (Gleason score 2-4) 2 (12%)
   Moderately differentiated (Gleason score 5-7) 5 (29%)
   Poorly differentiated or undifferentiated (Gleason score 8-10) 5 (29%)
Patient-rated overall bone pain**  
   Very mild 3 (18%)
   Mild 3 (18%)
   Moderate 8 (47%)
   Severe 2 (12%)
   Very severe 0
Pain relief medication ***  
   Ibuprofen 3 (18%)
   Percocet® (acetaminophen; oxycodone hydrochloride) 8 (47%)
   Lortab® (acetaminophen, hydrocodone bitartrate) 1 (6%)
   Oxycontin® (oxycodone hydrochloride) 5 (29%)
   Tylenol® (acetaminophen) 4 (24%)
   Zometa® (Zoledronic acid) 2 (12%)
   Vicodin® (acetominophen, hydrocodone bitartrate) 1 (6%)
   Darvocet® (acetominiphen; propoxyphen hydrocholoride) 1 (6%)
  1. *Missing data (n = 4) ** Missing data (n = 1) *** Patient could be receiving multiple pain relief medications